Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kg (BMN270-302)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03392974
Recruitment Status : Active, not recruiting
First Posted : January 8, 2018
Last Update Posted : September 5, 2019
Sponsor:
Information provided by (Responsible Party):
BioMarin Pharmaceutical

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 1, 2022
Estimated Study Completion Date : March 1, 2024